2009 Chapter Meeting Presentations 2008 Chapter Meeting Presentations 2007 Chapter Meeting Presentations Type-2 Diabetes Mellitus - Learn more about Type-2 Diabetes Mellitus since long-term complications of diabetes include CVD. In fact, two out of three people with diabetes die from CVD. 2009 Chapter Meeting Presentations: The 2009 PaACC Chapter Meeting was held October 2 - 4, 2009 at Skytop Lodge in Skytop, PA. Presentations from the meeting are listed here in an easy-to-use Adobe PDF format. After clicking on a file, click "open" to view the presentation, or save to your computer. ACC Cut the Cuts Campaign by Alfred A. Bove, MD, PhD, FACC Quality Aspect of Health Reform by Joseph G. Cacchione, MD Real-Time MRI Guided Intervention by Henry R. Halperin, MD, MA, FAHA Minimally Invasive Cardiac Surgery and Complex Valve Recinstruction by Y. Joseph Woo, MD Therapeutic Application of Stem Cells in Cardiovascular Disease by Oscar C. Marroquin, MD, FACC, FSCAI The Use of Cardiac CT and MRI in Clinical Practice by Matthew W. Martinez, MD New Developments In the Management of Aortic and Mitral Valve Disorders by Patricia A. Pellikka, MD Maintenance of Certification (MOC) for Cardiologists by Laura Wexler, MD, FAHA, FACC When to Cool? Clinical Applications of Therapeutic Hypothermia by Clifton W. Callaway, MD, PhD 2008 Chapter Meeting Presentations: The 2008 PaACC Chapter Meeting was held October 31st - November 2nd at the Hotel Hershey in Hershey, PA. Presentations from the meeting are listed here in an easy-to-use PPS (PowerPoint Show) format. After clicking on a file, click "open" to view the presentation. You do not need to have MS PowerPoint installed on your computer to view the files. Quality First by Alfred A. Bove, MD, PhD, FACC 2008 Update: Tools for the Management of Stable Angina A Brain; Heart; and COURAGE by Daniel Edmundowicz, MS, MD, FACC Percutaneous Valve Repair and Replacement by Howard C. Herrmann, MD, FACC Increased Awareness of Legislative and Regulatory Issues by C. Richard Schott, MD, FACC PCI vs Medical Therapy for Stable Angina by A.J. Conrad Smith, MD, FACC Treating Decompensated and Stage D Heart Failure by Ronald S. Freudenberger, MD, FACC CP / Emergence of Cardiac CT by William A. Van Decker, M.D. HDL: Still a target for therapy? by Daniel J. Rader, MD ICD Patients/Recalled ICDS: What to do? by Gerald V. Naccarelli M.D. 2007 Chapter Meeting Presentations: Presentations from the Annual Chapter Meeting held October 12-14, 2007. All files are in a MS PowerPoint Show (.PPS) format. You do not need to have MS PowerPoint Installed on your computer to view the files. Each link opens a new window. Transforming Science into Quality Care by Alfred A. Bove, MD, PhD Treat Everyone to an LDL-C or 70mg/dl? by Daniel Edmundowicz MS, MD, FACC Reimbursement Challenges and Solutions for Cardiovascular Specialists by Kathleen Flood, Director, Payer Advocacy Gloom, Doom, and the Baby Boom: HealthCare in the Future by Raymond J. Gibbons, MD [ File 1 ] [ File 2 ] Negotiating Your Employment Contract by Vasilios J.Kalogredis, Esq. Treatment of Atrial Fibrillation: 2007 Update by David L. Scher, FACP, FACC, FHRS Achieving Accreditation in Echo, Nuclear and Vascular by Robert Skotnicki DO, FACC LDL: Lower IS Better by Andrew R. Waxler, MD, FACC Task Force on Performance Assessment, Recognition, Reinforcement and Reward (PAR3) by Janet Wright MD, FACC Type-2 Diabetes Mellitus: T2DM Drivers Driver One Reducing blood glucose and HbA1c levels reduces the risk of diabetic complications. Intensive therapy has been shown to be superior to conventional therapy in terms of reducing glycemia and diabetic complications. Driver Two When monotherapy with an oral agent is no longer adequate, combination therapy with two or more oral agents has been shown to significantly improve glycemic control. Driver Three When oral monotherapy or combination oral therapy is no longer adequate, insulin can be added to the regimen to significantly improve glycemic control. Driver Four Benefits of insulin therapy, such as improved outcomes and glycemic control, outweigh risks such as the potential for inducing hypoglycemia. Driver Five Type 2 diabetes mellitus is a disease consisting of two components: insulin resistance and insulin deficiency. Read the full diabetes module for cardiology. This Scientific Evidence Based Medicine Module was funded by an educational grant from Sanofi-Aventis Pharmaceuticals Education Center.